Drug
SR604 clinical trials
- studies test it
- 5
- open now
- 5
- in phase 3
- 1
- first study started
- 2024
Keep track of what changes. Save the SR604 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
5 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 3
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
Shanghai RAAS Blood Products Co., Ltd. (4) · Equilibra Bioscience LLC (1)
Studies
Open first, then newest update. How each study uses SR604 is read from its arms, and is right about nine times in ten.
Testing it · 5
- A Phase III Clinical Trial Evaluating SR604 Injection for Prophylactic Treatment in Patients With HemophiliaNot yet recruitingPhase 3Shanghai RAAS Blood Products Co., Ltd.NCT07876674Written as SR604
- A Phase II Exploratory Study of SR604 Injection Evaluating the Safety and Efficacy in the Treatment of Congenital Coagulation Factor VII DeficiencyNot yet recruitingPhase 2Shanghai RAAS Blood Products Co., Ltd.NCT07711158Written as SR604
- A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)RecruitingPhase 1Equilibra Bioscience LLCNCT06349473Written as SR604
- An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII DeficiencyRecruitingPhase 1/2Shanghai RAAS Blood Products Co., Ltd.NCT07644832Written as SR604
- A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand DiseaseRecruitingPhase 2Shanghai RAAS Blood Products Co., Ltd.NCT07640893Written as SR604